How IVF became a licence to print money
By Fay Schopen,
The Guardian
| 06. 18. 2018
I don’t consider myself to be lucky. I have never won the lottery, or even found a fiver in an old coat pocket. But there is one aspect in life where fortune has smiled on me: I am eight months pregnant with my first child – the result of IVF treatment.
Around three-quarters of all IVF cycles fail. And results vary with age. Figures from the Human Fertilisation and Embryology Authority (HFEA) published in March state the average live birthrate for each fresh embryo transferred for women of all ages is 21%; for those aged under 35, it is 29% – the highest it has ever been. For older women, the picture is bleaker: 10% for women aged 40-42, for example.
In 2011, then aged 36, I underwent one cycle of IVF, funded by my local NHS trust, before I was treated for breast cancer. The embryos were frozen and in 2016 I embarked on the next stage: implantation. Funding was unavailable because I was by then over 40 and it was clear to me that IVF funding was unfair,...
Related Articles
By Editor, ReproTech Truths | 04.10.2019
In the last few years, ASRM has aggressively courted RESOLVE, once a purely grassroots group of women helping women get support for infertility. RESOLVE’s grassroots nationwide membership was its crown jewel.
Eager to gain access to RESOLVE’s membership, Big Pharma,...
By Drew Harwell, The Washington Post | 04.10.2019
Like millions of women, Diana Diller was a devoted user of the pregnancy-tracking app Ovia, logging in every night to record new details on a screen asking about her bodily functions, sex drive, medications and mood. When she gave birth...
DNA Testing, Medical Applications and Databases
The concept of merging DNA ancestry testing with forensic analysis is very disturbing. But there is much more – and potentially worse – happening. Merging both technologies with gene editing and also with medical applications is under active development. Both Jennifer Doudna and Feng Zhang, two of the three discoverers of CRISPR-Cas9, are involved with companies aiming for exactly this kind of synergy.
Meanwhile, security breaches of mega-databases seem to be increasingly common. And...
Direct-to-consumer genetic testing companies used to focus on ailments and ancestry, and were marketed directly to the people tested. But once you’ve been told what gruesome disease you have a one in six chance of developing, and where your great-grandparents might have lived, what’s next? Your children!
The pitch: Should your kids focus on music or math, reading or running, learning languages or dancing or drawing? Will they need help avoiding depression or combating shyness? Have them take a genetic...
